KEGG pathway analysis indicated that FHL1 was involved in the Janus kinase/signal transducer and activator of the transcription (JAK/STAT) signaling pathway, which was reported to be activated in NSCLC with EGFR mutation [42]. Here, EGFR is linked to non-small cell lung carcinoma.